Qingyuan Zhang1,2†
Gen Wu3†
Jianfei Chen4Kui Fang5Qianqian Liu1Pan Zhang1Hongzhen Zhu1*
Chunhua Zhang1*- 1Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
- 2Center of Structural Cardiology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China
- 3The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China
- 4Wuhan University, Wuhan, Hubei, China
- 5The First Hospital of China Medical University, Shenyang, Liaoning, China
Objective: To systematically evaluate and explore the factors influencing depressive symptoms in female breast cancer patients in China through meta-analysis.
Methods: Relevant data were retrieved from cross-sectional studies or cohort studies on depressive symptoms of Chinese breast cancer within the following databases: PubMed, Embase, Cohrane Library, Web of 105 Science, Database of Medical Literature (CBM), Wan Fang Data, CNKI, and VIP databases. The literature screening, data extraction and literature quality evaluation were performed by two researchers by carefully reading the title, abstract and full text, and meta-analysis was performed using Stata 1.5 software after extracting relevant data.
Results: Fourteen papers were finally included, with a cumulative total of 3,071 people surveyed, and a total of 1,298 breast cancer patients were detected with depression, with a detection rate of depressive symptoms of 42.26%; meta analysis showed that age less than 40 years old, unmarried, less than undergraduate education, monthly income <5,000 yuan, advanced breast cancer, radical breast cancer surgery, family history, living in rural areas, underlying disease stage and chemotherapy were associated with an increased incidence of depression in breast cancer patients.
Conclusion: The detection rate of depressive symptoms in female breast cancer patients is high, and there is a need to strengthen depression-related psychological screening of breast cancer patients and provide them with individualized interventions to reduce the incidence of depression in breast cancer patients and to lower the level of depression already present in the patients.
1 Introduction
According to the 2020 global cancer statistics reported by the International Agency for Research on Cancer (IARC), breast cancer has replaced lung cancer as the most common malignant tumor in the world, with 2.26 million new cases (Sung et al., 2021). While breast cancer survival rates have improved with modern medical technology, psychological problems abound (Jacob et al., 2016). Both the diagnosis of breast cancer itself and its treatment can lead to or exacerbate a patient’s mental health condition (Epping-Jordan et al., 1999; Drageset et al., 2012), depression is the most common form of psychological distress (Loeffler et al., 2018; Civilotti et al., 2020). According to Tsaras et al. the prevalence of depression in breast cancer patients was 38.2% (Tsaras et al., 2018). The results of a meta-analysis showed that the prevalence of depression in breast cancer patients was 32.2% (Pilevarzadeh et al., 2019). Many breast cancer patients experience high levels of psychological problems, such as depression, and this can have a negative impact on survival rates and quality of life for patients (Setyowibowo et al., 2022). In recent years, the depressive state of breast cancer patients has gradually attracted the attention of scholars at home and abroad, but the influencing factors of depression are still unclear and lack of relevant systematic evaluation in China. In this study, the results of published studies on factors related to depression in Chinese women with breast cancer were analyzed using meta-analysis to understand the influencing factors of depression in breast cancer and to lay the foundation for individualized interventions for breast cancer survivors with depressive symptoms.
2 Information and methods
2.1 Inclusion and exclusion criteria of the literature
Inclusion criteria: (1) The study subjects were Chinese female breast cancer patients with a clear diagnosis; (2) A scale was used to assess the degree of depressive symptoms in breast cancer patients; (3) The types of studies were cross-sectional, cohort, and case–control studies; (4) All retrievable literature in Chinese and English. Exclusion criteria: (1) literature with data that could not be extracted or transformed; (2) duplicate publications; (3) conference abstracts or reviews; and (4) low quality of literature: an AHRQ [Agency for Healthcare Research and Quality] score ≤ 3 (Zeng et al., 2012).
Search strategy using “breast cancer/breast cancer/breast tumor” and “depression/depressive symptoms” and “prevalence/detection rate/status” as the search terms, the Chinese search strategy was (“breast cancer” OR “breast cancer” OR “breast tumor”) AND ((“depression” OR “breast cancer” OR “breast tumor”) AND ((“depression” OR “breast cancer” OR “breast tumor”)). “Breast Cancer” OR “Breast Cancer” OR “Breast Tumor”)AND((“Depression” OR “depressive symptoms”) AND (“prevalence” detection rate “status”)), and the English search strategy was (“breast neoplasm*” OR “breast tumor*” OR “breast cancer “OR “Mammary cancer “) AND (“Depressive Symptom” OR “Depression”) AND (“Detection Rate “OR “Epidemiology” OR “Prevalence”). AND (“Chinese “OR “China”). Computerized search of English and Chinese databases: PubMed, Embase, Cohrane Library, Web of Science, Database of Medical Literature (CBM), Wan Fang Data, CNKI, and VIP databases. The search was conducted for studies on the occurrence of depressive symptoms in Chinese breast cancer patients before July 20, 2023, using a combination of breast cancer-related search terms and depression-related search terms.
2.2 Literature screening and data extraction
Literature screening and data extraction were performed by two researchers who independently screened the literature according to the inclusion and exclusion criteria using Endnote software, cross-checked the extracted data, and in the event of disagreement, a third researcher adjudicated. Information such as author, publication date, region, age, assessment tool, sample size, depressive symptom detection rate, cancer stage and influencing factors were extracted from the literature.
2.3 Quality evaluation of the included literature
Two researchers evaluated the risk of bias of the included studies by using the AHRQ quality evaluation scale, which consists of 11 items, with a score of 1 for a “yes” answer and 0 for a “no” or “unclear” answer. The scale consists of 11 items, with 1 point for “yes” and 0 points for “no” or “unclear.” The range goes from 0 to 11, where 0–3 is low quality, 4–7 is medium quality, and 8–11 is high quality (Zeng et al., 2012).
2.4 Statistical methods
Meta-analysis was performed using Stata 1.5 software. Effect sizes were described using ORs of factors related to depressive symptoms in breast cancer patients and their 95% CIs. The heterogeneity test was used to determine whether there was heterogeneity among the studies in the included literature; if p > 0.1 and I2 < 50%, suggesting that there was no obvious statistical heterogeneity among similar studies, a fixed-effects model was chosen; if p < 0.1 and I2 > 50%, suggesting that there was statistical heterogeneity, a random-effects model was chosen for the merger analysis; and by comparing the difference between the fixed-effects model and the merger of random-effects model, a sensitivity analysis was performed.
3 Results
3.1 Literature search results
After the initial search of 3,852 articles, Endnote X9 software was applied to exclude 300 duplicates, and 3,552 articles were obtained. After reading the topics and abstracts of the literature, 3,492 articles were obtained, and after reading the full text of the literature, 14 articles were finally included in the study after evaluation of the quality of the literature, with a total of 3,071 patients. The entire process is shown in Figure 1.
Figure 1. The flow chat of the identification of relevent studies.
3.2 Basic characteristics of the included literature
Fourteen literatures published in 2014–2021 were finally included, with a cumulative total of 3,071 patients; five studies were conducted in the north and nine in the south, covering a total of nine provinces across the country, with a total of 1,298 breast cancer patients detected with depression, and an overall detection rate of depressive symptoms of 42.26%. The basic characteristics are shown in Table 1.
Table 1. Basic characteristics of included studies.
3.3 Literature quality evaluation
The 14 included literature were of medium to high quality, all articles were cross-sectional studies and were evaluated according to the AHRQ recommendations; two (Liu et al., 2014; Xu et al., 2019) literature were evaluated as 8 “Yes”; two (Bai et al., 2018; Chen et al., 2019) literature were evaluated as 7 “Yes “; one (Wang and Xue, 2014) literature evaluated with 5 “yes”; and the remaining 9 literature (Xu et al., 2015; Liu, 2016; Lv et al., 2017, 2020; Yang, 2017; Zhu et al., 2017; Jin et al., 2018; Wang et al., 2020; Chen et al., 2021) evaluated with 6 “yes” Table 2.
Table 2. Risk of bias ratings for cross-sectional studies.
3.4 Meta-analysis results
The results of the heterogeneity test showed that there was significant heterogeneity among the literature related to each factor of age, marriage, education, disease stage, place of residence, chemotherapy, and the presence of family history (p < 0.1, I2 > 50%), so the random effects model was used to merge the effect sizes; the heterogeneity of the results of combining the factors of influence such as occupation, economy, mode of payment, surgical method, and the presence of underlying diseases was less heterogeneous (p > 0.1, I2 < 50%), so the fixed-effects model was used to combine effect sizes. Meta analysis showed that age less than 40 years old, unmarried, less than undergraduate education, monthly income less than 5,000 yuan, advanced breast cancer, radical breast cancer surgery, family history, living in rural areas, underlying disease stage and chemotherapy were associated with an increased incidence of depression in breast cancer patients (Table 3).
Table 3. Meta-analysis results of influencing factors of depressive symptoms in breast cancer patients.
3.5 Sensitivity analysis
Sensitivity analyses of the 12 factors included were conducted using the fixed-effects model and random effects respectively, and the results showed that the combined ORs of the two models and their 95% CIs were relatively close, indicating that the meta-analysis of this study was stable (Table 4).
Table 4. Sensitivity analysis of factors influencing depressive symptoms in breast cancer patients.
4 Discussion
Breast cancer is the most common malignant tumor in women, and the incidence rate is not only high but also on the rise year by year, which seriously affects the physical and mental health of women (Sung et al., 2021). The diagnosis of breast cancer itself not only leads to severe stressful psychological events, but also patients have to experience a series of adverse reactions such as pain, treatment side effects, and body image changes in the course of disease treatment, so most of the patients will experience different degrees of psychological disorders (Fortin et al., 2021). A review showed that >12% of women develop depressive symptoms after diagnosis of breast cancer (Fann et al., 2008). Depression not only affects patients’ psychological functioning, physiological functioning, treatment adherence, and quality of life, but is also an important factor contributing to the occurrence of mortality in breast cancer patients (Watson et al., 2005; Shim et al., 2020). Meta-analysis has shown that there is a significant correlation between depression and mortality in breast cancer (Satin et al., 2009; Giese-Davis et al., 2011), and meta-analysis by He et al. has shown that the prevalence of depression in female breast cancer patients in China is as high as 42.1% (He et al., 2023), seriously affecting the prognosis and quality of survival of patients, in order to prevent and control this mental health problem, clinical practitioners should identify the prevalent factors in patients at an early stage so that timely and effective interventions can be taken.
The discovery of risk factors for depression in breast cancer patients is an important condition for improving the psychological status of patients, and in this study, we found that age < 40 years, poor economic status, surgical methods, and the presence of genetic and family history are risk factors for depression in female breast cancer patients, which is in line with the findings of Puigpinós-Riera et al. (2018), the reason being that young and unmarried women are highly concerned about their self-image, focusing on their own appearance, and undergoing mastectomy is a great blow to them, with a decrease in self-esteem and self-efficacy, and fear that the disease will affect their marriages and childbearing, family stability, and careers (Shen et al., 2018). Patients with a family history and underlying disease tend to worry about prognosis and fear (Bayer et al., 2022).
The present study found that marital and employment status was a protective factor for the occurrence of depression in breast cancer patients, married and employed breast cancer patients are significantly less likely to develop depression, consistent with the findings of Casavilca-Zambrano et al. (2020) that employed and married patients were less likely to experience depressive symptoms, which was associated with higher emotional, family and economic levels of the patients. A previous study of 1,400 Chinese women found that employed and high-income women were less likely to experience depressive symptoms and they had a higher sense of social support (Chen et al., 2009). Patients with higher education also had a fuller understanding of the disease and better individual physical and mental regulation, and were less likely to experience negative emotions. Patients whose payments were covered by health insurance or commercial insurance had relatively less financial stress and consequently lower psychological stress (Li et al., 2019). The lower the tumor stage, the lower the likelihood of malignancy, metastasis, and recurrence, the higher the survival rate, and the significantly lower the occurrence of somatic symptoms and negative emotions in patients (Niu et al., 2019). Patients living in rural areas may be related to their “country-style” lifestyle, in which they try to see the positive outcome of the disease when facing breast cancer and are grateful for the possibility of treatment, maintaining optimism and reducing the worry of family members, and experiencing relatively little depression (Schlegel et al., 2009). Adverse effects such as nausea and vomiting occur in most patients during intravenous chemotherapy and chemotherapy as a risk factor in this study is consistent with the findings of Hajj et al. (2021) and others, but in Henselmans et al. (2010) and others reported a large group of women who did not experience mood disorders during chemotherapy. Therefore, further studies are needed to determine this variable.
The limitations of this study include: (1) the number of included literatures is not large enough and the sample size is small; the research design and analysis methods of the included studies vary greatly, which has some influence on the results; (2) the number of literatures included for individual influencing factors is small, which may have some influence on the conclusions of the meta-analysis; (3) a total of 14 literatures included in the present study involve six depression scales, and the survey entries for the different depression scales are different, and there may be a difference in the detection rate of the different scales, which may affect the results of the study; and (4) the present study is a cross sectional study conducted by means of the form of scales, and the individuals have not been subjected to a comprehensive psychological interview, which is not sufficiently comprehensive to investigate and analyze the influencing factors.
5 Conclusion
In summary, advanced age, poor economic status, radical mastectomy, family history, ongoing disease, and chemotherapy may increase the incidence of depression in breast cancer patients. Patients should undergo early prevention and timely intervention for the above risk factors after diagnosis of breast cancer, which plays an important role in decreasing the incidence and severity of depression.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Author contributions
QZ: Writing – original draft. GW: Writing – review & editing. JC: Writing – original draft. KF: Writing – original draft. QL: Writing – original draft. PZ: Writing – original draft. HZ: Writing – original draft. CZ: Writing – review & editing, Funding acquisition.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research is supported by the Joint Fund (WJ2018H0029) of the Health and Family Planning Commission of Hubei Province, China, in the year 2018.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Bai, L., Yi, S., Bai, W., Liu, W., Lu, Y., Zhang, T., et al. (2018). Investigation of the detection rate of depression and its risk factors in 137 breast cancer patients. Mil. Med. 42, 398–399. doi: 10.7644/j.issn.1674-9960.2018.05.018
Bayer, S. J., Yang, G. S., and Lyon, D. E. (2022). Genetic variation associated with depressive symptoms in breast Cancer patients: a systematic review. Cancer Nurs. 45, E197–e205. doi: 10.1097/NCC.0000000000000903
Casavilca-Zambrano, S., Custodio, N., Liendo-Picoaga, R., Cancino-Maldonado, K., Esenarro, L., Montesinos, R., et al. (2020). Depression in women with a diagnosis of breast cancer. Prevalence of symptoms of depression in Peruvian women with early breast cancer and related sociodemographic factors. Semin. Oncol. 47, 293–301. doi: 10.1053/j.seminoncol.2020.08.003
Chen, Y., Li, G., and He, Y. (2021). Study on psychological status and influencing factors of breast cancer patients in western Guangdong. South China Prevent. Med. 47, 540–542. doi: 10.12183/j.scjpm.2021.0540
Chen, J., Wang, H., Ding, J., and Zhang, H. (2019). Relationship between subthreshold depressive status and quality of social relationships in patients with first diagnosis of breast cancer. China Med. Herald 16, 37–40. doi: CNKI:SUN:YYCY.0.2019-02-010
Chen, X., Zheng, Y., Zheng, W., Gu, K., Chen, Z., Lu, W., et al. (2009). Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol. 48, 1128–1136. doi: 10.3109/02841860903188650
Civilotti, C., Acquadro Maran, D., Santagata, F., Varetto, A., and Stanizzo, M. R. (2020). The use of the distress thermometer and the hospital anxiety and depression scale for screening of anxiety and depression in Italian women newly diagnosed with breast cancer. Support Care Cancer 28, 4997–5004. doi: 10.1007/s00520-020-05343-x
Drageset, S., Lindstrøm, T. C., Giske, T., and Underlid, K. (2012). "The support I need": women's experiences of social support after having received breast cancer diagnosis and awaiting surgery. Cancer Nurs. 35, E39–E47. doi: 10.1097/NCC.0b013e31823634aa
Epping-Jordan, J. E., Compas, B. E., Osowiecki, D. M., Oppedisano, G., Gerhardt, C., Primo, K., et al. (1999). Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol. 18, 315–326. doi: 10.1037/0278-6133.18.4.315
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., et al. (2008). Major depression after breast cancer: a review of epidemiology and treatment. Gen. Hosp. Psychiatry 30, 112–126. doi: 10.1016/j.genhosppsych.2007.10.008
Fortin, J., Leblanc, M., Elgbeili, G., Cordova, M. J., Marin, M. F., and Brunet, A. (2021). The mental health impacts of receiving a breast cancer diagnosis: a meta-analysis. Br. J. Cancer 125, 1582–1592. doi: 10.1038/s41416-021-01542-3
Giese-Davis, J., Collie, K., Rancourt, K. M., Neri, E., Kraemer, H. C., and Spiegel, D. (2011). Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J. Clin. Oncol. 29, 413–420. doi: 10.1200/JCO.2010.28.4455
Hajj, A., Hachem, R., Khoury, R., Hallit, S., ElJEBBAWI, B., Nasr, F., et al. (2021). Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study. BMC Cancer 21:872. doi: 10.1186/s12885-021-08615-9
He, J., Gao, J., Bai, D., Zhang, H., Chen, H., and Gong, X. (2023). Meta-analysis of the detection rate of depressive symptoms in Chinese female breast cancer patients. Chin J. Ment. Health 37, 116–121. doi: 10.3969/j.issn.1000-6729.2023.02.004
Henselmans, I., Helgeson, V. S., Seltman, H., de Vries, J., Sanderman, R., and Ranchor, A. V. (2010). Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol. 29, 160–168. doi: 10.1037/a0017806
Jacob, L., Bleicher, L., Kostev, K., and Kalder, M. (2016). Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J. Cancer Res. Clin. Oncol. 142, 447–452. doi: 10.1007/s00432-015-2048-5
Jin, C., Wang, B., and Hu, J. (2018). Analysis of risk factors for postoperative depression in young and middle-aged female breast cancer patients. Chin. J. Front. Med. 10, 139–142. doi: 10.12037/YXQY.2018.10-32
Li, T., Tan, H., Chen, Y., Jiang, J., and Xiong, M. (2019). The relationship between psychological resilience and quality of life during chemotherapy in postoperative breast cancer patients and the analysis of its influencing factors. Cancer Prog. 17, 2343–2347. doi: 10.11877/j.issn.1672-1535.2019.17.19.30
Liu, W. (2016). A survey of depression in 151 breast cancer patients. Chin. Med. Herald 22, 36–37,49. doi: CNKI:SUN:HNZB.0.2016-16-015
Liu, Y. Z., Zhou, Q., Xie, Y. T., Chen, S. M., Zeng, Y. J., Luo, X. Z., et al. (2014). A study on the anxiety and depression status of female breast cancer patients and its influencing factors in the community of Guangzhou City, China. South China Prevent. Med. 40, 7–11. doi: CNKI:SUN:GDWF.0.2014-01-003
Loeffler, S., Poehlmann, K., and Hornemann, B. (2018). Finding meaning in suffering?-meaning making and psychological adjustment over the course of a breast cancer disease. Eur. J. Cancer Care (Engl) 27:e12841. doi: 10.1111/ecc.12841
Lu, J., Xu, G., Chen, H., Gao, D., and Feng, Z. (2020). Analysis of the occurrence of depression in breast cancer chemotherapy patients and its influencing factors. South China Prevent. Med. 46, 706–708. doi: 10.12183/j.scjpm.2020.0706
Lu, L., Zhang, X., Wang, X., and Zhang, J. (2017). A study of subthreshold depression and social participation in young and middle-aged postoperative breast cancer patients. J. Nurs. 32, 84–87. doi: 10.3870/j.issn.1001-4152.2017.06.084
Niu, L., Liang, Y., and Niu, M. (2019). Factors influencing fear of cancer recurrence in patients with breast cancer: evidence from a survey in Yancheng, China. J. Obstet. Gynaecol. Res. 45, 1319–1327. doi: 10.1111/jog.13978
Pilevarzadeh, M., Amirshahi, M., Afsargharehbagh, R., Rafiemanesh, H., Hashemi, S. M., and Balouchi, A. (2019). Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res. Treat. 176, 519–533. doi: 10.1007/s10549-019-05271-3
Puigpinós-Riera, R., Graells-Sans, A., Serral, G., Continente, X., Bargalló, X., Domènech, M., et al. (2018). Anxiety and depression in women with breast cancer: social and clinical determinants and influence of the social network and social support (DAMA cohort). Cancer Epidemiol. 55, 123–129. doi: 10.1016/j.canep.2018.06.002
Satin, J. R., Linden, W., and Phillips, M. J. (2009). Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115, 5349–5361. doi: 10.1002/cncr.24561
Schlegel, R. J., Talley, A. E., Molix, L. A., and Bettencourt, B. A. (2009). Rural breast cancer patients, coping and depressive symptoms: a prospective comparison study. Psychol. Health 24, 933–948. doi: 10.1080/08870440802254613
Setyowibowo, H., Yudiana, W., Hunfeld, J. A. M., Iskandarsyah, A., Passchier, J., Arzomand, H., et al. (2022). Psychoeducation for breast cancer: a systematic review and meta-analysis. Breast 62, 36–51. doi: 10.1016/j.breast.2022.01.005
Shen, Y., Zhang, J., Bu, Q., et al. (2018). A longitudinal study of the level of psychological distress in breast cancer patients and the factors influencing it. China Nurs Manage 18, 617–622. doi: 10.3969/j.issn.1672-1756.2018.05.009
Shim, E. J., Lee, J. W., Cho, J., Jung, H. K., Kim, N. H., Lee, J. E., et al. (2020). Association of depression and anxiety disorder with the risk of mortality in breast cancer: a National Health Insurance Service study in Korea. Breast Cancer Res. Treat. 179, 491–498. doi: 10.1007/s10549-019-05479-3
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249. doi: 10.3322/caac.21660
Tsaras, K., Papathanasiou, I. V., Mitsi, D., Veneti, A., Kelesi, M., Zyga, S., et al. (2018). Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac. J. Cancer Prev. 19, 1661–1669. doi: 10.22034/APJCP.2018.19.6.1661
Wang, L., Liu, D., and Chen, K. (2020). Analysis of anxiety and depression status and related factors in breast cancer surgery patients. Int. J. Psychiatry 47, 1222–1225.
Wang, L., and Xue, F. (2014). Analysis of the occurrence of postoperative depression and related risk factors in women with breast cancer(Chinese article). Med. Clin. Res. 3, 529–531. doi: 10.3969/j.issn.1671-7171.2014.03.041
Watson, M., Homewood, J., Haviland, J., and Bliss, J. M. (2005). Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur. J. Cancer 41, 1710–1714. doi: 10.1016/j.ejca.2005.01.012
Xu, Y., Zhang, S., and Zhang, H. (2019). Postoperative depressive states and factors affecting them in breast cancer patients. Chin. J. Health Psychol. 27, 369–372. doi: CNKI:SUN:JKXL.0.2019-03-014
Xu, N., Zhang, P., Zhou, D., Liu, C., Zhang, Y., and Wang, Y. (2015). Survey on postoperative depression status of breast cancer patients and analysis of risk factors. Chin. J. Mod. Med. 25, 68–72. doi: 10.3969/j.issn.1005-8982.2015.34.016
Yang, X. (2017). Analysis of factors influencing depression psychology in breast cancer patients. Hebei Med. 23, 1423–1426.
Zeng, X., Liu, H., Chen, X., and Leng, W. (2012). Meta-analysis series IV: a quality assessment tool for observational studies. Chin. J. Evid. Based Cardiovasc. Med. 4, 297–299. doi: 10.3969/j.1674-4055.2012.04.004
Keywords: breast cancer, depression, related factors, meta-analysis, female patients
Citation: Zhang Q, Wu G, Chen J, Fang K, Liu Q, Zhang P, Zhu H and Zhang C (2024) Factors influencing depressive symptoms in Chinese female breast cancer patients: a meta-analysis. Front. Psychol. 15:1332523. doi: 10.3389/fpsyg.2024.1332523
Edited by:
Valeria Sebri, European Institute of Oncology (IEO), ItalyReviewed by:
Xingchen Peng, Sichuan University, ChinaIndira Karibayeva, Georgia Southern University, United States
Copyright © 2024 Zhang, Wu, Chen, Fang, Liu, Zhang, Zhu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongzhen Zhu, 527540787@qq.com; Chunhua Zhang, zhangchua@whu.edu.cn
†These authors have contributed equally to this work